Načítá se...
Repeatability of (18)F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma
Quantitative 3′-deoxy-3′-(18)F-fluorothymidine ((18)F-FLT) PET has potential as a noninvasive tumor biomarker for the objective assessment of response to treatment. To guide interpretation of these quantitative data, we evaluated the repeatability of (18)F-FLT PET as part of a multicenter trial invo...
Uloženo v:
| Vydáno v: | J Nucl Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Society of Nuclear Medicine
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5331936/ https://ncbi.nlm.nih.gov/pubmed/27688473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.116.178434 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|